Antitrust and Intellectual Property

Similar documents
Patents and Standards The American Picture. Judge Randall R. Rader U.S. Court of Appeals for the Federal Circuit

RAMBUS, INC. v. FEDERAL TRADE COMMISSION Impact on Standards and Antitrust

ANSI Legal Issues Forum Washington, D.C. October 12, 2006 Antitrust Update

Antitrust/Intellectual Property Interface Under U.S. Law

Clarifying Competition Law: Interface between Intellectual Property Rights and EU/U.S. Competition/Antitrust Law. Robert S. K.

STANDARD SETTING AND ANTITRUST: SSOs, SEPs, F/RAND AND THE PATENT HOLDUP. Jeffery M. Cross Freeborn & Peters LLP

Patent Portfolio Management and Technical Standard Setting: How to Avoid Loss of Patent Rights. Bruce D. Sunstein 1 Bromberg & Sunstein LLP

Federal Circuit Provides Guidance on Methodologies for Calculating FRAND Royalty Rates, Vacating the Jury Award in Ericsson v.

PCI SSC Antitrust Compliance Guidelines

CPI Antitrust Chronicle March 2015 (1)

Re: In the Matter of Robert Bosch GmbH, FTC File No

Antitrust IP Competition Perspectives

The Antitrust Review of the Americas 2017

Intellectual Ventures Wins Summary Judgment to Defeat Capital One s Antitrust Counterclaims

APLI Antitrust & Licensing Issues Panel: SEP Injunctions

EU Advocate General Opines That Seeking Injunctions On FRAND-Encumbered SEPs May Constitute an Abuse of Dominance

Pharmaceutical Patent Settlement Cases: Mixed Signals for Settling Patent Litigation

FTC AND DOJ ISSUE JOINT REPORT REGARDING ANTITRUST ENFORCEMENT AND INTELLECTUAL PROPERTY RIGHTS

District Court Denies Motion to Dismiss FTC Section 5 Complaint Against Qualcomm

Avoiding Trade Association Antitrust Pitfalls. Jan P. Levine Megan Morley

Law in the Global Marketplace: Intellectual Property and Related Issues FRAND Commitments and Obligations for Standards-Essential Patents

DOJ Issues Favorable BRL on Proposed Revisions to IEEE s Patent Policy

Pharmaceutical Product Improvements and Life Cycle Management Antitrust Pitfalls 1

AIPLA Comments on Questionnaire on IP Misuse Antitrust Guidelines

Rambus Addresses Some Questions, Raises Others

2 Noerr-Pennington Rulings Affirm Narrow Scope Of Immunity

IN THE PAST THREE YEARS, A NUMBER

August 6, AIPLA Comments on Partial Amendment of Guidelines for the Use of Intellectual Property Under the Antimonopoly Act (Draft)

Patents, Standards and Antitrust: An Introduction

Challenging Anticompetitive Acquisitions and Enforcement of Patents *

Standard-Setting, Competition Law and the Ex Ante Debate

Intellectual Property Rights and Antitrust Liability in the U.S.: The 2016 Landscape. Jonathan Gleklen Yasmine Harik Arnold & Porter LLP

Defenses & Counterclaims II: Remedies:

PAYING FOR DELAY AND THE RULE OF REASON FEDERAL TRADE COMMISSION V ACTAVIS INC ET AL 1

WHY THE SUPREME COURT WAS CORRECT TO DENY CERTIORARI IN FTC V. RAMBUS

Standard-Setting Policies and the Rule of Reason: When Does the Shield Become a Sword?

FRAND or Foe: Litigating Standard Essential Patents

Looking Within the Scope of the Patent

ALI-ABA Course of Study PRODUCT DISTRIBUTION AND MARKETING. San Francisco June 10, 2015

Risks of Grant-back Provisions in Licensing Agreements: A Warning to Patent-heavy Companies

3 Tex. Intell. Prop. L.J. 1. Texas Intellectual Property Law Journal Fall, 1994 ANTITRUST COUNTERCLAIMS IN PATENT AND COPYRIGHT INFRINGEMENT CASES

Product Improvements and Life Cycle Management Antitrust Pitfalls

Antitrust and Intellectual Property: Recent Developments in the Pharmaceuticals Sector

January 3, General Comments

Federal Court Dismisses Claims Against NPE for Allegedly Fraudulently Enforcing Its Patents; Upholds Breach of Contract and Promissory Estoppel Claims

FTC v. Actavis, Inc.: When Is the Rule of Reason Not the Rule of Reason?

Health Care Law Monthly

1 Manufacturer Manufacturer Manufacturer 2 Distributor Distributor Distributor Distributor Distributor Distributor 3 Consumers

Suture Express, Inc. v. Owens & Minor Distrib., Inc., 851 F.3d 1029 (10th Cir.)

Injunctive Relief for Standard-Essential Patents

Pay-for-Delay Settlements: Antitrust Violation or Proper Exercise of Pharmaceutical Patent Rights?

Antitrust Regulation of IPRs China s First Proposal

DIRECT PURCHASERS STANDING TO SUE FOR WALKER PROCESS FRAUD IN RE: DDAVP DIRECT PURCHASER ANTITRUST LITIGATION

MODULE C - LEGAL SUBMODULES C1.

From PLI s Program New Strategies Arising from the Hatch-Waxman Amendments #4888

FTC Orders Compulsory IP Licensing to Remedy Competitive Concerns in Honeywell/Intermec Transaction

UNITED STATES INTERNATIONAL TRADE COMMISSION Washington, D.C. THIRD PARTY UNITED STATES FEDERAL TRADE COMMISSION S STATEMENT ON THE PUBLIC INTEREST

International Competition Network Unilateral Conduct Working Group Questionnaire

A Response to Chief Justice Roberts: Why Antitrust Must Play a Role in the Analysis of Drug Patent Settlements

GODZILLA vs MECHAGODZILLA

A Review of Korean Competition Law and Guidelines for Exercise of Standardrelated

Recent Trends in Patent Damages

1 of 1 DOCUMENT. BROADCOM CORPORATION, Appellant v. QUALCOMM INCORPORATED. No UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT

SUPREME COURT OF THE UNITED STATES

Court Approves 24.3 Million in Attorneys' Fees in Pay-For- Delay Litigation

The Patent Misuse Doctrine: A Balance of Patent Rights and the Public Interest

Standards Related Patents and Standard Setting Organizations Navigating the Challenges of SSOs: Licensing, Disclosure and Litigation

Patents, Tying and Market Power: The Implications of ITW v. Independent Ink for Antitrust Claims Against IP Owners

Patent Deception in Standard Setting: The Case for Antitrust Policy

Non-challenge clauses in the TTBER and beyond: implications for litigation and settlements. Sophie Lawrance, Senior Associate Bristows LLP 8 May 2015

AIPLA Annual Meeting, Washington DC 23 October Licenses in European Patent Litigation

Court Dismisses NPE s Group Boycott Claims Against RPX, Motorola, Samsung, and Others

Intellectual Property and Section 90.1 of the Competition Act

THE FUTURE OF STANDARD SETTING

From Walker Process to In re DDAVP: Should Direct Purchasers Have Antitrust Standing in Walker Process Claims?

ANTITRUST AND INTELLECTUAL PROPERTY: A BRIEF INTRODUCTION

Intellectual Property E-Bulletin

Case 1:05-cv JDT-TAB Document 30 Filed 11/28/2005 Page 1 of 12 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF INDIANA INDIANAPOLIS DIVISION

Patent Portfolio Licensing

Court in Microsoft v. Motorola Dismisses Injunctive Relief for Motorola Asserted Patents and Motorola s Entire H.264 SEP Portfolio

NTT DOCOMO Technical Journal. Akimichi Tanabe Takuya Asaoka Katsunori Tsunoda Makoto Kijima. 1. Introduction

BLIZZARD ENTERTAINMENT INC. v. CEILING FAN SOFTWARE LLC, et al., 41 F.Supp.2d 1227 (C.D. Cal. 2013)

Case5:12-cv RMW Document41 Filed10/10/12 Page1 of 10

The New IP Antitrust Licensing Guidelines' Silence On SEPs

12/6/ :35:59 AM

The Antitrust Review of the Americas 2013

TITLE: IrDA INTELLECTUAL PROPERTY POLICY

Graduate Industrial Organization Some Notes on Antitrust.

International Competition Network Unilateral Conduct Working Group Questionnaire. Refusal to Deal

Protection of trade secrets through IPR and unfair competition law

Legal Constraints On Corporate Participation In Standards Setting Do s and Don ts By Eric D. Kirsch 1

Increased Scrutiny of Reverse Payment Settlements: Recent Cases in E.D. of PA and 2nd Circuit Suggest Change May Be Ahead for Pharma Clients

10 TH ANNUAL HEALTH CARE PRACTITIONER S ROUNDTABLE VBA HEALTH LAW SECTION

Patent Holdup, Patent Remedies, and Antitrust Responses The Role of Patent Remedies and Antitrust Law in Dealing with Patent Holdups

Technology and IP Forum: Current global issues in SEP licensing, enforcement, and disputes December 4, 2018

International Competition Network Unilateral Conduct Working Group Questionnaire

February I. General Comments

High-Tech Patent Issues

Fordham Intellectual Property Law Institute. Wolfgang von Meibom

A Rational Thinking on the Refusal to License Intellectual Property under China s Antitrust Legal Framework. Dr. Zhan Hao & Ms.

Transcription:

and Intellectual Property July 22, 2016 Rob Kidwell, Member

Antitrust Prohibitions vs IP Protections The Challenge Harmonizing U.S. antitrust laws that sanction the illegal use of monopoly/market power with patent laws that grant limited monopoly. 2

1. Overview of Antitrust Laws A. Sherman Act 1 "Every contract, combination in the form of trust or otherwise, or conspiracy, in restraint of trade or commerce" B. Sherman Act 2 "Monopolize, or attempt to monopolize, or combine or conspire with any other person or persons, to monopolize any part of the trade or commerce " C. Clayton 7 "The effect of such acquisition may be substantially to lessen competition, or to tend to create a monopoly" 3

2. Evolution of Antitrust Treatment of Patents A. DOJ's "9 No-Nos" Presumptively Unlawful Licensing Practices (1970) tying the purchase of unpatented materials as a condition of the license; requiring a licensee to assign back subsequent patents; restricting the resale right of a product's purchasers; restricting a licensee's ability to deal in products outside the scope of the patent; prohibiting a licensor from granting further licenses; requiring mandatory package licensing; requiring, as a condition of the license, royalties not reasonably related to the licensee's sales of products covered by the patent; restricting a licensee's use of a product made by a patented process; and setting minimum resale price provisions for licensed products 4

2. Evolution of Antitrust Treatment of Patents (cont'd) B. Flexible Approach in 1995 DOJ/FTC Intellectual Property Guidelines " The intellectual property laws and the antitrust laws share the common purpose of promoting innovation and enhancing consumer welfare. The intellectual property laws provide incentives for innovation The antitrust laws promote innovation and consumer welfare by prohibiting certain actions that may harm competition." General Principles for the purpose of antitrust analysis, the Agencies regard intellectual property as being essentially comparable to any other form of property; the Agencies do not presume that intellectual property creates market power in the antitrust context; and the Agencies recognize that intellectual property licensing allows firms to combine complementary factors of production and is generally procompetitive 5

2. Evolution of Antitrust Treatment of Patents (cont'd) C. Illinois Tool Works, Inc. v. Independent Ink, Inc., 547 U.S. 28 (2006) Abandoned presumption that intellectual property confers market or monopoly power. Thus, in an antitrust claim involving a tying arrangement where the allegedly tying product is patented, the plaintiff must prove that the patent owner has market power in the patented product. 6

3. Basic Issues at the Intersection of Antitrust and IP A. Bad faith enforcement litigation can, in theory, constitute an antitrust violation under the "sham" exception to the Noerr-Pennington doctrine, which generally holds that the mere bringing of a lawsuit cannot itself constitute an antitrust violation. Walker Process Equip. Inc. v. Food Mach. & Chem. Corp., 382 U.S. 172 (1965) Supreme Court held that enforcement of a patent procured by fraud can violate Section 2 of Sherman Act. Walker Process counterclaims often brought as counter-claims to infringement actions. 7

3. Basic Issues at the Intersection of Antitrust and IP (cont'd) B. Patent Pooling and Assignments In United States v. Singer Manufacturing Co., 374 U.S. 174 (1963) transfer of a patent found to violate Section 1 in context of broader monopolistic scheme. An exclusive license can require, in certain circumstances, the same U.S. antitrust filing as a merger. Patent pooling among competitors is analyzed under the antitrust rule of reason and is often permissible. Standard Oil Co. v. United States, 283 U.S. 163 (1931). Basic rule of thumb - if ancillary to legitimate procompetitive goal, likely ok. But, if used to restrain competition, perhaps not, e.g., Zenith Radio Corp. v. Hazeltine Research, 395 U.S. 100 (1969). 8

4. 1995 Antitrust Guidelines for Licensing of Intellectual Property A. Normal antitrust analysis applies to IP Rights. B. Ownership of IP Rights, on its own, does not convey market power. C. Licensing is generally pro-competitive and subject to rule of reason. D. Innovation market "the research and development directed to particular new or improved goods or processes" will be analyzed as a distinct market. E. Antitrust safety zone for licensing arrangements under 20%. 9

5. Three Hot Topics A. Standard Setting B. FRAND C. Reverse Payments/Pay for Delay 10

A. Hot Topic Standard Setting A. Procompetitive Benefit of Standard Setting The development of standards through industry collaboration can produce necessary/beneficial interoperability standards and performance standards B. Antitrust Risk The standard-setting process often involves communication and deliberation among competitors; Particularly where a trade association is involved, a standard adopted by a group of competitors may discriminates against other competitors 11

Standard Setting (cont'd) American Society of Mechanical Engineers v. Hydrolevel Corp., 456 U.S. S. 556 (1986) Violation found where association members conspired to release code interpretation unfavorable to competitors Allied Tube & Conduit Corp. v. Indian Head, Inc., 486 U.S. 492 (1988) Violation found where association members conspired to release code interpretation unfavorable to competitor 12

Standard Setting (cont'd) FTC Activity on Standard-Setting Dell Computer Corp., 121 FTC 616 (1995) FTC sued Dell for failing to disclose while participating in the standard-setting process that it owned a "blocking patent" incorporated into standard and then attempted to enforce patent rights once standard was adopted. In settlement, Dell agreed not to enforce. Rambus, Inc. v. FTC, 522 F.3d 456 (D.C. Cir. 2008) Rambus was accused of antitrust violation by intentionally deceiving the JEDEC during SDRAM standard setting. FTC's finding of violation was reversed in court because court held that the FTC had not demonstrated that standard would have been different if Rambus had disclosed. 13

Standard Setting (cont'd) Institute of Electrical and Electronic Engineers ("IEEE") - DOJ Feb. 2015 Business Review Letter IEEE's Revised Policy Companies agreeing to the IEEE RAND commitment must offer to license patents to all requesting parties, without picking and choosing licensees, and cannot seek an injunction against potential licensees who are willing to negotiate for a license "Reasonable rate" must not include the value derived from the fact that the patent is included in the standard (i.e. basing the royalty rate on the smallest saleable unit by focusing on the intrinsic value of the technology) May demand a reciprocal license in return Should ensure that subsequent purchasers of the patent are bound by these agreements 14

B. Hot Topic FRAND/RAND What's Antitrust Got To Do With It? The question of applying competition/antitrust laws to FRAND licensing and contracts is "hot" around the world. This focuses on the United States. "Hold Up" Issue An entity with a SEP even when making a FRAND/RAND commitment may hold up the potential licensee for unfair and anticompetitive rates or use rate negotiations to renege on the commitment generally The FTC and particularly the DOJ have been actively suggesting that the hold up problem is real, and an antitrust remedy potentially necessary (the DOJ IEEE letter is reflective of this view) Some Question Whether "Hold Up" is a Problem If it is a problem, is contract law sufficient to address it? Would antitrust policy drive royalty rates below market value? 15

FRAND/RAND (cont'd): Microsoft v. InterDigital, D. Del, filed Aug. 2015. Microsoft brought Section 2 Sherman Act claim, alleging abusive licensing practices and unlawful monopolization in relevant markets for 3G and 4G cellular technologies, including "false promises to make its technologies available on FRAND terms." In February 2016, district court denied InterDigital's Motion to Dismiss, finding that Microsoft had sufficiently pled anticompetitive conduct. The complaint alleges that [InterDigital] made an "intentional false promise that [it] would license its... technology on FRAND terms, on which promise [ETSI] relied in choosing the... technology for inclusion in the" relevant standards. This conduct "induced ETSI to adopt a technology "that they would not have considered absent a FRAND commitment." Following the incorporation of its technology, the complaint alleges, [InterDigital] refused to comply with its FRAND licensing obligations. Microsoft alleged specific ways in which InterDigital exploited its unlawfully acquired power against Microsoft. 16

FRAND/RAND (cont'd): Microsoft Allegations Against InterDigital (cont'd) Refused to honor the obligation to license its patents on FRAND terms; Demanded excessive and discriminatory royalties from companies that sell 3G and 4G devices; Tied access to its U.S. patents to its foreign patents along with the requirement that licensees pay royalties on worldwide sales; Tied access to its SEPs to licensing of its admittedly non-essential patents; Transferred hundreds of SEPs to a controlled entity in order to "double dip" in its royalty demands; Misappropriated technical information submitted by other standards members so that it could obtain patents in its name and accordingly profit from technologies created by others; Discriminated in its pricing demands against Microsoft based on Microsoft's smaller market share relative to Microsoft's competitors; Tied access to its SEPs and proposed license terms for them to prospective licensee's agreement to enter mandatory non-disclosure terms while refusing to disclose license terms provided to Microsoft's competitors in order to hide InterDigital's discriminatory pricing; and Pursued baseless infringement actions and baseless demands for injunctive relief and exclusion orders designed to increase Microsoft's costs and thereby coerce Microsoft to capitulate to InterDigital's unreasonable, non-frand demands. 17

C. Hot Topic Reverse Payments/Pay for Delay Settlements in the pharmaceutical industry that result from the structure of the Hatch-Waxman Act. These agreements involve structures where patent holders agree to make a payment to the challenger of the underlying patent. The effect of the agreements is to delay the point at which the competitor enters the market. For the last decade, the FTC has made it an antitrust enforcement priority to pursue such agreements as anticompetitive. Parties had defended these settlements as immune from antitrust attack so long as the anticompetitive effects fell within the scope of the exclusionary or the patent. 18

Reverse Payments/Pay for Delay (cont'd) Reverse Payment Cases FTC v. Actavis, Inc., 570 US 756 (2013) Held that reverse payments can sometimes violate antitrust laws. But, declined to hold that reverse payments are presumptively unlawful. Instead, courts should analyze the settlement agreement under the antitrust rule of reason. The Supreme Court said that the likelihood of a reverse payment bringing about anticompetitive effects depends upon its size, its scale in relation to the payor's future litigation costs, its independence from other services for which it might represent payment, and the lack of any other convincing justification. The Supreme Court left it to the lower courts to sort out. 19

Reverse Payments/Pay for Delay (cont'd) Actavis in the Lower Courts Two Circuit Courts have held that a lack of a cash payment does not doom a reverse payment antitrust case, but Actavis can be applied to payments that don't take the form of cash. In one of the cases, the drug companies have asked that the Supreme Court review that ruling. One case has been tried to a jury which found for the defendants. That case, involving Nexium, is on appeal. The FTC has several cases pending. In FTC v. Endo Pharmaceuticals, the FTC brought pay-for-delay claims over no authorized generics agreements as "the currency" for delaying the generic manufacturer's entry into market. 20

Thank you! 21